Overview

Studies of Left Ventricular Dysfunction (SOLVD)

Status:
Completed

Trial end date:
1990-05-01

Target enrollment:

Participant gender:

Summary

To determine if enalapril treatment of left ventricular dysfunction (LVD) due to ischemic or hypertensive heart disease led to reduced mortality and morbidity in symptomatic and asymptomatic patients. There were a Prevention Trial, a Treatment Trial, and a registry.

Phase:

Phase 3

Details

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Enalapril